We identify and grow early biotech, medtech, and deeptech startups — bringing network, technical, and commercial expertise, working at-risk for equity.
We're experienced operators embedded in your company — not coaches, not investors at arm's length. We work at-risk for equity, so we only win when you do.
No cohorts. Every engagement is bespoke — we embed in your business.
No LPs, no conflicts. We invest our most scarce resource: expert time.
No hourly fees. We work at-risk for equity.
Network, domain knowledge, and hands-on execution — through commercialization.
We embed in your organization to validate market opportunity and define the go-to-market strategy.
We provide or facilitate pre-angel capital to bridge the hardest financing gap in deep-tech.
We activate our network to drive revenue and position the company for institutional investment or acquisition.
Market creation, commercialization, M&A, and federal funding — translating early-stage technology into commercial strategy.
Biotech and global pharma operator — lab to market, building technical teams, and scientific portfolio management.